Clinical Trial Update: 24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed Combination [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating 24-hour intraocular pressure control with a fixed combination of travoprost and timolol has completed. The study enrolled participants …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Exfoliation Syndrome
• Open-angle Glaucoma

Drugs mentioned

• Travoprost/Timolol fixed combination (travoprost; timolol)

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Primary Open Angle Glaucoma, Exfoliation Syndrome | Phase 3 | Status: COMPLETED